These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 29725804)
1. Validation of the EPIPHANY index for predicting risk of serious complications in cancer patients with incidental pulmonary embolism. Ahn S; Cooksley T; Banala S; Buffardi L; Rice TW Support Care Cancer; 2018 Oct; 26(10):3601-3607. PubMed ID: 29725804 [TBL] [Abstract][Full Text] [Related]
2. Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index. Carmona-Bayonas A; Jiménez-Fonseca P; Font C; Fenoy F; Otero R; Beato C; Plasencia JM; Biosca M; Sánchez M; Benegas M; Calvo-Temprano D; Varona D; Faez L; de la Haba I; Antonio M; Madridano O; Solis MP; Ramchandani A; Castañón E; Marchena PJ; Martín M; Ayala de la Peña F; Vicente V Br J Cancer; 2017 Apr; 116(8):994-1001. PubMed ID: 28267709 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer. Li X; Hu Y; Lin P; Zhang J; Tang Y; Yi Q; Liang Z; Zhou H; Wang M Thromb Haemost; 2021 Jun; 121(6):834-844. PubMed ID: 33450779 [TBL] [Abstract][Full Text] [Related]
4. [Pulmonary embolism in patients with cancer: foundations of the EPIPHANY study]. Font C; Carmona-Bayonas A; Plasencia JM; Calvo-Temprano D; Sánchez M; Jiménez-Fonseca P; Beato C; Biosca M; Vicente V; Otero R; Med Clin (Barc); 2015 Jan; 144 Suppl 1():31-7. PubMed ID: 25771090 [TBL] [Abstract][Full Text] [Related]
5. Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study. Sánchez-Cánovas M; Jimenez-Fonseca P; Fernández Garay D; Cejuela Solís M; Casado Elía D; Coma Salvans E; de la Haba Vacas I; Gómez Sánchez D; Fernández Montés A; Morales Giménez R; Biosca Gómez de Tejada M; Arrazubi Arrula V; Sequero López S; Otero Candelera R; Sánchez Cendra C; Justo de la Peña M; Moreno Muñoz D; Orillo Sarmiento M; Martínez de Castro E; García Escobar I; Bernal Vidal A; Ortega Moran L; Muñoz Martín AJ; Sánchez Bayona R; Martínez Ortiz MJ; Ayala de la Peña F; Vicente V; Carmona-Bayonas A PLoS One; 2023; 18(5):e0266305. PubMed ID: 37159465 [TBL] [Abstract][Full Text] [Related]
6. Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original? Vinson DR; Ballard DW; Mark DG; Huang J; Reed ME; Rauchwerger AS; Wang DH; Lin JS; Kene MV; Pleshakov TS; Sax DK; Sax JM; McLachlan DI; Yamin CK; Swap CJ; Iskin HR; Vemula R; Fleming BS; Elms AR; Aujesky D; Thromb Res; 2016 Dec; 148():1-8. PubMed ID: 27764729 [TBL] [Abstract][Full Text] [Related]
7. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. den Exter PL; Gómez V; Jiménez D; Trujillo-Santos J; Muriel A; Huisman MV; Monreal M; Chest; 2013 Jan; 143(1):138-145. PubMed ID: 22814859 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Treatment Setting in Patients With Cancer Having Pulmonary Embolism: Comparison With the Pulmonary Embolism Severity Index. Ahn S; Lee YS; Kim WY; Lim KS; Lee JL Clin Appl Thromb Hemost; 2017 Sep; 23(6):615-621. PubMed ID: 26759372 [TBL] [Abstract][Full Text] [Related]
9. PERC rule to exclude the diagnosis of pulmonary embolism in emergency low-risk patients: study protocol for the PROPER randomized controlled study. Freund Y; Rousseau A; Guyot-Rousseau F; Claessens YE; Hugli O; Sanchez O; Simon T; Riou B Trials; 2015 Nov; 16():537. PubMed ID: 26607669 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics, management, and outcome of incidental pulmonary embolism in cancer patients. Qdaisat A; Kamal M; Al-Breiki A; Goswami B; Wu CC; Zhou S; Rice TW; Alagappan K; Yeung SJ Blood Adv; 2020 Apr; 4(8):1606-1614. PubMed ID: 32311012 [TBL] [Abstract][Full Text] [Related]
11. Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Jiménez D; Kopecna D; Tapson V; Briese B; Schreiber D; Lobo JL; Monreal M; Aujesky D; Sanchez O; Meyer G; Konstantinides S; Yusen RD; On Behalf Of The Protect Investigators Am J Respir Crit Care Med; 2014 Mar; 189(6):718-26. PubMed ID: 24471575 [TBL] [Abstract][Full Text] [Related]
12. Incidental pulmonary embolism in cancer and noncancer patients: Prospective cohort study. Wysokinska EM; Houghton DE; Vlazny DT; Ashrani AA; Froehling DA; Meverden R; Hodge DO; Peterson LG; McBane RD; Wysokinski WE; Casanegra AI Eur J Haematol; 2023 Jan; 110(1):88-98. PubMed ID: 36210612 [TBL] [Abstract][Full Text] [Related]
13. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. den Exter PL; Hooijer J; Dekkers OM; Huisman MV J Clin Oncol; 2011 Jun; 29(17):2405-9. PubMed ID: 21555690 [TBL] [Abstract][Full Text] [Related]
14. External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active Cancer. Weeda ER; Caranfa JT; Zeichner SB; Coleman CI; Nguyen E; Kohn CG J Natl Compr Canc Netw; 2017 Dec; 15(12):1476-1482. PubMed ID: 29223985 [No Abstract] [Full Text] [Related]
15. Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study. Font C; Carmona-Bayonas A; Beato C; Reig Ò; Sáez A; Jiménez-Fonseca P; Plasencia JM; Calvo-Temprano D; Sanchez M; Benegas M; Biosca M; Varona D; Vicente MA; Faez L; Solís MD; de la Haba I; Antonio M; Madridano O; Castañon E; Martinez MJ; Marchena P; Ramchandani A; Dominguez A; Puerta A; Martinez de la Haza D; Pueyo J; Hernandez S; Fernandez-Plaza A; Martinez-Encarnacion L; Martin M; Marin G; Ayala F; Vicente V; Otero R; Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28052954 [TBL] [Abstract][Full Text] [Related]
16. Keeping prognostic assessment simple: The value of clinical features in normotensive cancer patients with pulmonary embolism. Moura Ferreira J; Moura-Ferreira S; Baptista R; Ferreira R; Madaleno J; Silva N; Ferreira MJ; Pego M Rev Port Cardiol (Engl Ed); 2019 Jun; 38(6):407-415. PubMed ID: 31307728 [TBL] [Abstract][Full Text] [Related]
17. Special Considerations in Pulmonary Embolism: Clot-in-Transit and Incidental Pulmonary Embolism. Kabrhel C; Rosovsky R; Garvey S Crit Care Clin; 2020 Jul; 36(3):531-546. PubMed ID: 32473697 [TBL] [Abstract][Full Text] [Related]
18. Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism. Shin SH; Kang D; Cho J; Chang H; Kim MS; Lee SY; Lee H; Kim H; Kim DK; Kim EK; Park HY Int J Chron Obstruct Pulmon Dis; 2018; 13():937-943. PubMed ID: 29593386 [TBL] [Abstract][Full Text] [Related]
19. Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous ThromboEmbolism Registry (SWIVTER). Spirk D; Aujesky D; Husmann M; Hayoz D; Baldi T; Frauchiger B; Banyai M; Baumgartner I; Kucher N Thromb Haemost; 2011 Nov; 106(5):978-84. PubMed ID: 21833454 [TBL] [Abstract][Full Text] [Related]
20. External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Kohn CG; Weeda ER; Kumar N; Wells PS; Peacock WF; Fermann GJ; Wang L; Baser O; Schein JR; Crivera C; Coleman CI Intern Emerg Med; 2017 Aug; 12(5):613-619. PubMed ID: 28185131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]